IL1A and acute respiratory distress syndrome: These pathways may drive the production of additional cytokines (e.g., IL-1α, IL-1ß, IL-4, IL-6, IFN-γ, and IFN-β), which could have downstream effects on disease severity and the risk of developing conditions like ARDS [35].